Incyte Corporation (INCY)

NASDAQ
80.96
-3.40(-4.03%)
After Hours
80.73
-0.23(-0.28%)
- Real-time Data
  • Volume:
    4,158,856
  • Day's Range:
    79.08 - 83.75
  • 52 wk Range:
    65.07 - 86.29
Unusual trading volume

Incyte has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

INCY Overview

Prev. Close
84.36
Day's Range
79.08-83.75
Revenue
3.33B
Open
83.5
52 wk Range
65.07-86.29
EPS
3.95
Volume
4,158,856
Market Cap
18.01B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,494,971
P/E Ratio
20.26
Beta
0.723
1-Year Change
10.37%
Shares Outstanding
222,475,468
Next Earnings Date
May 02, 2023
What is your sentiment on Incyte?
or
Market is currently closed. Voting is open during market hours.

Incyte Corporation News

Incyte Corporation Analysis

Incyte Corporation Company Profile

Incyte Corporation Company Profile

Employees
2094

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise is comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellBuy
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Buy
SummaryStrong BuyBuyStrong SellStrong SellStrong Buy
  • 40
    0
    • To da moon
      1
      • not working for me
        2
        • antes Arias Santi Arias
          3
          • Google play Khmer🌟
            0
            • Why is this guy down?
              1
              • What is going on this stock? It has been dipping with no limit?!
                1
                • asc
                  0
              • beat Earnings, why down?
                3
                • Turkish biotechnology company produces RTALB diagnostic kit. Its products are in demand in 15 countries. The company has exported more than 2 million kits in the past month.
                  3
                  • This is why the stock lost 44% for the year? Who said $175?
                    1